ログインで組織・契約価格をご覧ください。
サイズを選択してください
表示を変更する
この商品について
実験式（ヒル表記法）:
C17H20N4O6
CAS番号:
分子量:
376.36
UNSPSC Code:
41116107
NACRES:
NA.24
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
97825
grade
pharmaceutical primary standard
API family
riboflavin
manufacturer/tradename
USP
mp
290 °C (dec.) (lit.)
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-8°C
SMILES string
CC1=C(C)C=C(N(C[C@H](O)[C@@H]([C@H](O)CO)O)C(C2=N3)=NC(NC2=O)=O)C3=C1
InChI
1S/C17H20N4O6/c1-7-3-9-10(4-8(7)2)21(5-11(23)14(25)12(24)6-22)15-13(18-9)16(26)20-17(27)19-15/h3-4,11-12,14,22-25H,5-6H2,1-2H3,(H,20,26,27)/t11-,12+,14-/m0/s1
InChI key
AUNGANRZJHBGPY-SCRDCRAPSA-N
General description
この製品は薬局方標準品です。発行元の薬局方により製造・供給されています。MSDSを含む製品情報などの詳しい情報は、発行元の薬局方のウェブサイトよりご確認ください。
Application
Riboflavin USP reference standard for use in specified quality tests and assays.
Also used to prepare standard, and standard stock Riboflavin solution for assay, identification, and performance test according to the given below monographs and general chapters of United States Pharmacopeia (USP):
Also used to prepare standard, and standard stock Riboflavin solution for assay, identification, and performance test according to the given below monographs and general chapters of United States Pharmacopeia (USP):
- Riboflavin
- Riboflavin Tablets
- Water-Soluble Vitamins Preparation
- 〈481〉 Riboflavin Assay
Analysis Note
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
Other Notes
Sales restrictions may apply.
Still not finding the right product?
Explore all of our products under (−)-リボフラビン
保管分類
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
Riboflavin Tablets
United States Pharmacopeia, 41(6), 3870-3870 (2017)
Water-Soluble Vitamins Preparation
United States Pharmacopeia, 45(5) (2021)
Olivier Richoz et al.
Investigative ophthalmology & visual science, 55(9), 5783-5787 (2014-07-24)
When treating peripheral ectatic disease-like pellucid marginal degeneration (PMD), corneal cross-linking with UV-A and riboflavin (CXL) must be applied eccentrically to the periphery of the lower cornea, partly irradiating the corneal limbus. Here, we investigated the effect of standard and